Asia-Pacific Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological and Synthetic) By Source (Contact Manufacturing Organizations and In-House Manufacturing) By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others) By Molecule Type (Small and Large) By Potency (Low and High) By Drug Type (Innovator and Generics) By Country, Competition, Forecast & Opportunities, 2028F

Asia Pacific active pharmaceutical ingredient market is projected to boom in the upcoming five years while exhibiting an impressive CAGR. An over the counter (OTC) or prescription drug's produces desired medical effects because of the active pharmaceutical ingredient (API) present in it. Some medications, including combination therapy, contain a number of APIs that may work differently or address various symptoms. For instance, the main ingredient in Tylenol, acetaminophen, is a well-known example of an API. Hence API is the key component of a formulation through which the formulation produces a desired medical effect.

China is a major active pharmaceutical ingredient producer in the Asia Pacific region which helps in fulfilling the global demand of API. China has been exporting tons of APIs to different parts of the globe for drug production. The sudden outbreak and spread of pandemic COVID-19 and imposition of lockdown and restriction on trade in order to curb the virus highlighted the importance of dependency on China for APIs. As a result of this, the Government of India launched a Production Linked Incentive Scheme under which more than 50 APIs would be indigenously produced in India to reduce dependency on China and make India self sufficient and emerge out as a leader in API supply and production. The emergence of India as a API producer and China being a leader will create lucrative opportunities for the growth of Asia Pacific Active Pharmaceutical Ingredient Market in the coming years.

The development in the production of active pharmaceutical ingredients (APIs) as well as the increased incidence of chronic diseases including cancer and cardiovascular conditions are both responsible for the market expansion of active pharmaceutical ingredients. Government regulations that are supportive of API manufacturing, together with shifting geopolitical conditions, are accelerating market growth. The market for active pharmaceutical ingredients (APIs) is also expected to grow as a result of increased technological advancements improving the capabilities and boosting manufacturing skills of market participants. Moreover, the market for active pharmaceutical ingredients (APIs) is also expected to have more growth potential as research funding for API development continues to rise. Hence, the market is expected to grow at significant rate during the forecast period.

Demand for Precision Medicines

The demand for precision medicines in the Asia Pacific is expected to grow at a significant rate during the forecast period owing to healthcare awareness, along with the adoption of advanced diagnosis methods. Additionally, the rising incidence of chronic diseases and the region's expanding population have increased the demand for sequencing technologies. Further, precision medicine is gaining more attention from the healthcare system, clinicians, governments, and pharmaceutical companies. FDA approvals and advancements in precision medicines have boosted market expansion during the forecast period. Additionally, the market is expanding due to the growing acceptance of precision medicine, which is fueling increased research and development for the selection of the most effective treatment based on molecular analysis of tumors and preclinical studies. This in turn is anticipated to drive market expansion.

Increasing Disease Burden

The growing geriatric population in the region especially in countries like Japan, China and India which is susceptible to various injuries, falls, diseases, among others has significantly increased the demand for active pharmaceutical ingredients in the region. According to the Ministry of Internal Affairs and Communications, as of September 15, 2022, the total population of Japan fell by 820,000 over the last year. At the same time, the number of seniors aged 65 years and above increased by 60,000 for a record total of 36.27 million. This is an increase by 0.03% from that in 2021. According to Global Burden of Disease, Injuries, and Risk Factors (GBD), Central Asia reported the highest age-standardized number of deaths from cardiovascular causes. Additionally, the incidence of diabetes, cancer, renal disorders, respiratory problems, among others have also increased significantly in the region over the last few years.

Download Free Sample Report

Market Segmentation

Asia Pacific Active Pharmaceutical Ingredient Market is segmented into the method of synthesis, source, and application, molecule type, potency, and drug type. Based on the method of synthesis, the market is categorized into biological, and synthetic. Based on the source the market is divided into Contact Manufacturing Organizations, and In-House Manufacturing, based on the application the market is segmented into cardiovascular diseases, anti-diabetic drugs, oncology drugs, neurological disorders, musculoskeletal disorders, and Others. Based on molecule type the segment is divided into small and large. Based on potency the market is categorized into low and high. Based on drug type and the market is divided into innovator and generic.

Recent Developments

·      AbbVie Inc. and Scripps Research partnered in December 2019 to advance research for the development of novel drugs that target a variety of disorders, including oncology and immunology, among other areas. In accordance with the terms of the collaboration agreement, Scripps Research is expected to carry out the pre-clinical research tasks required for the creation of innovative treatments. This partnership aided the business in developing novel treatments for patients, which ultimately increased sales.

Market Players

Cipla Limited, Pfizer, Inc., Dr. Reddy's Laboratories Ltd., Symbiotica Speciality Ingredients Sdn. Bhd., ScinoPharm Taiwan Ltd, Zhejiang Hisun Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., AbbVie Inc., AstraZeneca plc, GlaxoSmithKline plc, Sanofi S.A., Lupin Limited, Nanjing Pharmaceutical Factory Co. Ltd., among others are some of the key players operating in the Asia Pacific Active Pharmaceutical Ingredient Market.

Report Scope:

In this report, Asia-Pacific active pharmaceutical ingredient market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Asia-Pacific Active Pharmaceutical Ingredient Market, By Method of Synthesis:
• Biological
• Synthetic
• Asia-Pacific Active Pharmaceutical Ingredient Market, By Source:

o   Contract Manufacturing Organizations

o   In-House Manufacturing

• Asia-Pacific Active Pharmaceutical Ingredient Market, By Therapeutic Application:

o   Cardiovascular Diseases

o   Anti-diabetic Drugs

o   Oncology Drugs

o   Neurological Disorders

o   Musculoskeletal Disorders

o   Others

• Asia-Pacific Active Pharmaceutical Ingredient Market, By Molecule Type:

o   Small

o   Large

• Asia-Pacific Active Pharmaceutical Ingredient Market, By Potency:
• Low
• High
• Asia-Pacific Active Pharmaceutical Ingredient Market, By Drug Type:
• Innovator
• Generics
• Asia-Pacific Active Pharmaceutical Ingredient Market, By Country:
• China
• India
• Japan
• South Korea
• Taiwan
• Vietnam
• Philippines
• Indonesia
• Malaysia
• Australia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Asia Pacific active pharmaceutical ingredient market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Asia-Pacific Active Pharmaceutical Ingredient Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]